MaxCyte, Inc. (MXCT) Financial Statements (2024 and earlier)

Company Profile

Business Address 9713 KEY WEST AVENUE,
ROCKVILLE, MD 20850
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments227,340255,044
Cash and cash equivalents11,06547,782
Short-term investments216,275207,261
Receivables11,6556,877
Inventory, net of allowances, customer advances and progress billings8,5815,205
Inventory8,5815,205
Other undisclosed current assets4,6913,307
Total current assets:252,266270,433
Noncurrent Assets
Operating lease, right-of-use asset9,8545,689
Property, plant and equipment23,7257,681
Long-term investments and receivables  
Long-term investments  
Other noncurrent assets809317
Total noncurrent assets:34,38713,687
TOTAL ASSETS:286,653284,120
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5321,820
Accounts payable5321,820
Deferred revenue6,7136,747
Other undisclosed current liabilities8,1827,051
Total current liabilities:15,42715,618
Noncurrent Liabilities
Long-term debt and lease obligation:  5,155
Liabilities, other than long-term debt17,260450
Other liabilities1,322450
Operating lease, liability15,9385,155
Total noncurrent liabilities:17,2605,605
Total liabilities:32,68621,223
Equity
Equity, attributable to parent253,967262,897
Common stock1,0241,012
Additional paid in capital390,819376,190
Accumulated deficit(137,875)(114,305)
Total equity:253,967262,897
TOTAL LIABILITIES AND EQUITY:286,653284,120

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
Revenues44,26233,894
Operating lease, lease income15,51312,323
Cost of revenue
(Cost of Goods and Services Sold)
(5,098)(3,647)
Gross profit:39,16330,247
Operating expenses(66,524)(48,435)
Operating loss:(27,361)(18,189)
Nonoperating income (expense)3,711(815)
Investment income, nonoperating  151
Other nonoperating income (expense)3,790(894)
Interest and debt expense  (5)
Loss from continuing operations before income taxes:(23,650)(19,009)
Income tax expense (3,241) 
Other undisclosed loss from continuing operations  
Loss from continuing operations:(26,890)(19,009)
Loss before gain (loss) on sale of properties:(19,009)
Other undisclosed net income (loss)3,320(73)
Net loss available to common stockholders, diluted:(23,571)(19,082)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
Net loss:(23,571)(19,082)
Comprehensive loss, net of tax, attributable to parent:(23,571)(19,082)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: